{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T07:41:08Z","timestamp":1781854868432,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T00:00:00Z","timestamp":1554854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Project of Science and Technology Research and Development of China Railway Corporation","award":["J2017Z603"],"award-info":[{"award-number":["J2017Z603"]}]},{"name":"Special Project of Profession","award":["201402007"],"award-info":[{"award-number":["201402007"]}]},{"name":"Foundation for young of Beijing shijitan hospital","award":["(2018-q13)"],"award-info":[{"award-number":["(2018-q13)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00198-019-04959-y","type":"journal-article","created":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T21:57:19Z","timestamp":1554933439000},"page":"1511-1519","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Genome-wide analysis of differentially expressed lncRNA in sporadic parathyroid tumors"],"prefix":"10.1007","volume":"30","author":[{"given":"T.","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. J.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. X.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. L.","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X. A.","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z. W.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X. Y.","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,10]]},"reference":[{"issue":"8","key":"4959_CR1","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.5858\/2008-132-1251-PHACP","volume":"132","author":"RA DeLellis","year":"2008","unstructured":"DeLellis RA, Mazzaglia P, Mangray S (2008) Primary hyperparathyroidism: a current perspective. Arch Pathol Lab Med 132(8):1251\u20131262","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"4959_CR2","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nrendo.2012.102","volume":"8","author":"KM Schulte","year":"2012","unstructured":"Schulte KM, Talat N (2012) Diagnosis and management of parathyroid cancer. Nat Rev Endocrinol. 8(10):612\u2013622","journal-title":"Nat Rev Endocrinol."},{"issue":"9","key":"4959_CR3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/jmg.40.9.657","volume":"40","author":"VM Howell","year":"2003","unstructured":"Howell VM, Haven CJ, Kahnoski K, Khoo SK, Petillo D, Chen J, Fleuren GJ, Robinson BG, Delbridge LW, Philips J, Nelson AE, Krause U, Hammje K, Dralle H, Hoang-Vu C, Gimm O, Marsh DJ, Morreau H, Teh BT (2003) HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet 40(9):657\u2013663","journal-title":"J Med Genet"},{"issue":"18","key":"4959_CR4","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1056\/NEJMoa031237","volume":"349","author":"TM Shattuck","year":"2003","unstructured":"Shattuck TM, V\u00e4lim\u00e4ki S, Obara T, Gaz RD, Clark OH, Shoback D, Wierman ME, Tojo K, Robbins CM, Carpten JD, Farnebo LO, Larsson C, Arnold A (2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349(18):1722\u20131729","journal-title":"N Engl J Med"},{"issue":"3","key":"4959_CR5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1365-2265.2007.02894.x","volume":"67","author":"CJ Haven","year":"2007","unstructured":"Haven CJ, van Puijenbroek M, Tan MH, Teh BT, Fleuren GJ, van Wezel T, Morreau H (2007) Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas. Clin Endocrinol 67(3):370\u2013376","journal-title":"Clin Endocrinol"},{"issue":"2","key":"4959_CR6","doi-asserted-by":"publisher","first-page":"E360","DOI":"10.1210\/jc.2014-3238","volume":"100","author":"W Yu","year":"2015","unstructured":"Yu W, McPherson JR, Stevenson M et al (2015) Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion. J Clin Endocrinol Metab 100(2):E360\u2013E364","journal-title":"J Clin Endocrinol Metab"},{"issue":"7464","key":"4959_CR7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/nature12548","volume":"500","author":"AM Schmitt","year":"2013","unstructured":"Schmitt AM, Chang HY (2013) Gene regulation: long RNAs wire up cancer growth. Nature. 500(7464):536\u2013537","journal-title":"Nature."},{"issue":"7235","key":"4959_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nature07672","volume":"458","author":"M Guttman","year":"2009","unstructured":"Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, Huarte M, Zuk O, Carey BW, Cassady JP, Cabili MN, Jaenisch R, Mikkelsen TS, Jacks T, Hacohen N, Bernstein BE, Kellis M, Regev A, Rinn JL, Lander ES (2009) Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 458(7235):223\u2013227","journal-title":"Nature."},{"issue":"4","key":"4959_CR9","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.3390\/cancers7040884","volume":"7","author":"A Silva","year":"2015","unstructured":"Silva A, Bullock M, Calin G (2015) The clinical relevance of long non-coding RNAs in Cancer. Cancers (Basel) 7(4):2169\u20132182","journal-title":"Cancers (Basel)"},{"issue":"3","key":"4959_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nrendo.2014.229","volume":"11","author":"M Knoll","year":"2015","unstructured":"Knoll M, Lodish HF, Sun L (2015) Long non-coding RNAs as regulators of the endocrine system. Nat Rev Endocrinol 11(3):151\u2013160","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"4959_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25(1):25\u201329","journal-title":"Nat Genet"},{"issue":"1","key":"4959_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1677\/ERC-09-0134","volume":"17","author":"S Corbetta","year":"2010","unstructured":"Corbetta S, Vaira V, Guarnieri V, Scillitani A, Eller-Vainicher C, Ferrero S, Vicentini L, Chiodini I, Bisceglia M, Beck-Peccoz P, Bosari S, Spada A (2010) Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue. Endocr Relat Cancer 17(1):135\u2013146","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"4959_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.suronc.2014.03.005","volume":"23","author":"A Al-Kurd","year":"2014","unstructured":"Al-Kurd A, Mekel M, Mazeh H (2014) Parathyroid carcinoma. Surg Oncol 23(2):107\u2013114","journal-title":"Surg Oncol"},{"issue":"8","key":"4959_CR14","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1001\/archsurg.136.8.878","volume":"136","author":"E Kebebew","year":"2001","unstructured":"Kebebew E, Arici C, Duh QY, Clark OH (2001) Localization and reoperation results for persistent and recurrent parathyroid carcinoma. Arch Surg 136(8):878\u2013885","journal-title":"Arch Surg"},{"issue":"5","key":"4959_CR15","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1530\/EJE-06-0720","volume":"156","author":"F Cetani","year":"2007","unstructured":"Cetani F, Ambrogini E, Viacava P, Pardi E, Fanelli G, Naccarato AG, Borsari S, Lemmi M, Berti P, Miccoli P, Pinchera A, Marcocci C (2007) Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma. Eur J Endocrinol 156(5):547\u2013554","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"4959_CR16","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/cncr.24037","volume":"115","author":"GG Fernandez-Ranvier","year":"2009","unstructured":"Fernandez-Ranvier GG, Khanafshar E, Tacha D, Wong M, Kebebew E, Duh QY, Clark OH (2009) Defining a molecular phenotype for benign and malignant parathyroid tumors. Cancer. 115(2):334\u2013344","journal-title":"Cancer."},{"issue":"2","key":"4959_CR17","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1210\/jc.2008-1740","volume":"94","author":"VM Howell","year":"2009","unstructured":"Howell VM, Gill A, Clarkson A, Nelson AE, Dunne R, Delbridge LW, Robinson BG, Teh BT, Gimm O, Marsh DJ (2009) Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. J Clin Endocrinol Metab 94(2):434\u2013441","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"4959_CR18","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1007\/s00268-014-2700-2","volume":"38","author":"PP Truran","year":"2014","unstructured":"Truran PP, Johnson SJ, Bliss RD, Lennard TW, Aspinall SR (2014) Parafibromin, galectin-3, PGP9.5, Ki67, and cyclin D1: using an immunohistochemical panel to aid in the diagnosis of parathyroid cancer. World J Surg 38(11):2845\u20132854","journal-title":"World J Surg"},{"issue":"3","key":"4959_CR19","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s12020-016-0997-3","volume":"54","author":"Y Hu","year":"2016","unstructured":"Hu Y, Liao Q, Cao S, Gao X, Zhao Y (2016) Diagnostic performance of parafibromin immunohistochemical staining for sporadic parathyroid carcinoma: a meta-analysis. Endocrine. 54(3):612\u2013619","journal-title":"Endocrine."},{"issue":"1","key":"4959_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11864-011-0171-3","volume":"13","author":"CH Wei","year":"2012","unstructured":"Wei CH, Harari A (2012) Parathyroid carcinoma: update and guidelines for management. Curr Treat Options in Oncol 13(1):11\u201323","journal-title":"Curr Treat Options in Oncol"},{"key":"4959_CR21","doi-asserted-by":"crossref","unstructured":"Murugan AK, Munirajan AK, Alzahrani AS (2018) Long noncoding RNAs: emerging players in thyroid cancer pathogenesis. Endocr Relat Cancer 25(2):R59\u2013R82","DOI":"10.1530\/ERC-17-0188"},{"key":"4959_CR22","doi-asserted-by":"crossref","unstructured":"Perlis N, Al-Kasab T, Ahmad A, Goldberg E, Fadak K, Sayid R, Finelli A, Kulkarni G, Hamilton R, Zlotta A, Ghai S, Fleshner N (2018) Defining a cohort that may not require repeat prostate biopsy based on PCA3 score and magnetic resonance imaging: the dual negative effect. J Urol 199(5):1182\u20131187","DOI":"10.1016\/j.juro.2017.11.074"},{"issue":"10\u201311","key":"4959_CR23","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.clinbiochem.2013.10.023","volume":"47","author":"S Dijkstra","year":"2014","unstructured":"Dijkstra S, Mulders PF, Schalken JA (2014) Clinical use of novel urine and blood based prostate cancer biomarkers: a review. Clin Biochem 47(10\u201311):889\u2013896","journal-title":"Clin Biochem"},{"key":"4959_CR24","first-page":"2645904","volume":"2017","author":"D Zhang","year":"2017","unstructured":"Zhang D, Liu X, Wei B, Qiao G, Jiang T, Chen Z (2017) Plasma lncRNA GAS8-AS1 as a potential biomarker of papillary thyroid carcinoma in Chinese patients. Int J Endocrinol 2017:2645904","journal-title":"Int J Endocrinol"},{"issue":"1","key":"4959_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.molonc.2013.10.003","volume":"8","author":"K Leelahavanichkul","year":"2014","unstructured":"Leelahavanichkul K, Amornphimoltham P, Molinolo AA, Basile JR, Koontongkaew S, Gutkind JS (2014) A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis. Mol Oncol 8(1):105\u2013118","journal-title":"Mol Oncol"},{"key":"4959_CR26","first-page":"1801","volume":"9","author":"HJ Zhang","year":"2016","unstructured":"Zhang HJ, Tao J, Sheng L, Hu X, Rong RM, Xu M, Zhu TY (2016) Twist2 promotes kidney cancer cell proliferation and invasion by regulating ITGA6 and CD44 expression in the ECM-receptor interaction pathway. Onco Targets Ther 9:1801\u20131812","journal-title":"Onco Targets Ther"},{"issue":"19","key":"4959_CR27","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1091\/mbc.E14-12-1584","volume":"26","author":"V Hoskin","year":"2015","unstructured":"Hoskin V, Szeto A, Ghaffari A, Greer PA, C\u00f4t\u00e9 GP, Elliott BE (2015) Ezrin regulates focal adhesion and invadopodia dynamics by altering calpain activity to promote breast cancer cell invasion. Mol Biol Cell 26(19):3464\u20133479","journal-title":"Mol Biol Cell"},{"issue":"2","key":"4959_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrc2584","volume":"9","author":"C Whibley","year":"2009","unstructured":"Whibley C, Pharoah PD, Hollstein M (2009) p53 polymorphisms: cancer implications. Nat Rev Cancer 9(2):95\u2013107","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4959_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ncb2641","volume":"15","author":"PA Muller","year":"2013","unstructured":"Muller PA, Vousden KH (2013) p53 mutations in cancer. Nat Cell Biol 15(1):2\u20138","journal-title":"Nat Cell Biol"},{"key":"4959_CR30","doi-asserted-by":"publisher","first-page":"5433","DOI":"10.1038\/ncomms6433","volume":"5","author":"JH Jo","year":"2014","unstructured":"Jo JH, Chung TM, Youn H, Yoo JY (2014) Cytoplasmic parafibromin\/hCdc73 targets and destabilizes p53 mRNA to control p53-mediated apoptosis. Nat Commun 5:5433","journal-title":"Nat Commun"},{"issue":"3","key":"4959_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/jmcb\/mju013","volume":"6","author":"A Zhang","year":"2014","unstructured":"Zhang A, Xu M, Mo YY (2014) Role of the lncRNA-p53 regulatory network in cancer. J Mol Cell Biol 6(3):181\u2013191","journal-title":"J Mol Cell Biol"},{"key":"4959_CR32","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1074\/jbc.M112.425736","volume":"288","author":"MI Rather","year":"2013","unstructured":"Rather MI, Nagashri MN, Swamy SS, Gopinath KS, Kumar A (2013) Oncogenic microRNA-155 down-regulates tumor suppressor CDC73 and promotes oral squamous cell carcinoma cell proliferation: implications for cancer therapeutics. J Biol Chem 288:608\u2013618","journal-title":"J Biol Chem"},{"key":"4959_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1677\/ERC-09-0291","volume":"17","author":"MA Hahn","year":"2010","unstructured":"Hahn MA, Howell VM, Gill AJ, Clarkson A, Weaire-Buchanan G, Robinson BG, Delbridge L, Gimm O, Schmitt WD, Teh BT, Marsh DJ (2010) CDC73\/HRPT2 CpG island hypermethylation and mutation of 5\u2032-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors. Endocr Relat Cancer 17:273\u2013282","journal-title":"Endocr Relat Cancer"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-04959-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-019-04959-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-04959-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T18:36:27Z","timestamp":1663266987000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-019-04959-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,10]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["4959"],"URL":"https:\/\/doi.org\/10.1007\/s00198-019-04959-y","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,10]]},"assertion":[{"value":"4 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}